Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In Canada, all of these weight loss medications can be used in adult patients with an initial body mass index (BMI) of: 30 Kg/m2 or greater, or 27 Kg/m2 or greater in the presence of at least one weight-related comorbidity (ie, high blood pressure, type 2 diabetes, high cholesterol, fatty liver, sleep apnea, etc) To find out if any of these agents are covered on your benefits plan, use each of the drug identification numbers (DIN) listed below each medication name to check with your benefits plan or pharmacy
Important safety considerations from the FDA label include: Zepbound is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis Zepbound may reduce the effectiveness of oral contraceptives
from Harvard and his M.D
It belongs to a new class of drugs called dual GIP and GLP-1 receptor agonistsmeaning it mimics the action of two natural gut hormones: GIP (Glucose-Dependent Insulinotropic Polypeptide) GLP-1 (Glucagon-Like Peptide-1) Together, these hormones help regulate blood sugar, digestion, hunger, and fat metabolismmaking Tirzepatide one of the most comprehensive weight management tools available today
